CRISPR interference identifies vulnerable cellular pathways with bactericidal phenotypes in Mycobacterium tuberculosis
- PMID: 34346123
- DOI: 10.1111/mmi.14790
CRISPR interference identifies vulnerable cellular pathways with bactericidal phenotypes in Mycobacterium tuberculosis
Abstract
Mycobacterium tuberculosis remains a leading cause of death for which new drugs are needed. The identification of drug targets has been advanced by high-throughput and targeted genetic deletion strategies. Each though has limitations including the inability to distinguish between levels of vulnerability, lethality, and scalability as a molecular tool. Using mycobacterial CRISPR interference in combination with phenotypic screening, we have overcome these individual issues to investigate essentiality, vulnerability and lethality for 94 target genes from a diverse array of cellular pathways, many of which are potential antibiotic targets. Essential genes involved in cell wall synthesis and central cellular functions were equally vulnerable and often had bactericidal consequences. Conversely, essential genes involved in metabolism, oxidative phosphorylation, or amino acid synthesis were less vulnerable to inhibition and frequently bacteriostatic. In conclusion, this study provides novel insights into mycobacterial genetics and biology that will help to prioritize potential drug targets.
Keywords: CRISPR interference; mycobacteria; tuberculosis.
© 2021 John Wiley & Sons Ltd.
Similar articles
-
Utilization of CRISPR interference to investigate the contribution of genes to pathogenesis in a macrophage model of Mycobacterium tuberculosis infection.J Antimicrob Chemother. 2022 Feb 23;77(3):615-619. doi: 10.1093/jac/dkab437. J Antimicrob Chemother. 2022. PMID: 34850009
-
Utilization of CRISPR Interference To Validate MmpL3 as a Drug Target in Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2019 Jul 25;63(8):e00629-19. doi: 10.1128/AAC.00629-19. Print 2019 Aug. Antimicrob Agents Chemother. 2019. PMID: 31160289 Free PMC article.
-
Investigating essential gene function in Mycobacterium tuberculosis using an efficient CRISPR interference system.Nucleic Acids Res. 2016 Oct 14;44(18):e143. doi: 10.1093/nar/gkw625. Epub 2016 Jul 12. Nucleic Acids Res. 2016. PMID: 27407107 Free PMC article.
-
Strategies of genome editing in mycobacteria: Achievements and challenges.Tuberculosis (Edinb). 2016 May;98:132-8. doi: 10.1016/j.tube.2016.03.005. Epub 2016 Mar 26. Tuberculosis (Edinb). 2016. PMID: 27156629 Review.
-
Systems-level modeling of mycobacterial metabolism for the identification of new (multi-)drug targets.Semin Immunol. 2014 Dec;26(6):610-22. doi: 10.1016/j.smim.2014.09.013. Epub 2014 Oct 23. Semin Immunol. 2014. PMID: 25453232 Review.
Cited by
-
High-throughput functional genomics: A (myco)bacterial perspective.Mol Microbiol. 2023 Aug;120(2):141-158. doi: 10.1111/mmi.15103. Epub 2023 Jun 6. Mol Microbiol. 2023. PMID: 37278255 Free PMC article. Review.
-
Chemical approaches to unraveling the biology of mycobacteria.Cell Chem Biol. 2023 May 18;30(5):420-435. doi: 10.1016/j.chembiol.2023.04.014. Cell Chem Biol. 2023. PMID: 37207631 Free PMC article. Review.
-
Unraveling the mechanisms of intrinsic drug resistance in Mycobacterium tuberculosis.Front Cell Infect Microbiol. 2022 Oct 17;12:997283. doi: 10.3389/fcimb.2022.997283. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36325467 Free PMC article. Review.
-
Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis.Front Cell Infect Microbiol. 2022 Aug 24;12:980844. doi: 10.3389/fcimb.2022.980844. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36093195 Free PMC article. Review.
-
Mutations in rv0678 Confer Low-Level Resistance to Benzothiazinone DprE1 Inhibitors in Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0090422. doi: 10.1128/aac.00904-22. Epub 2022 Aug 3. Antimicrob Agents Chemother. 2022. PMID: 35920665 Free PMC article.
References
REFERENCES
-
- Awasthy, D., Gaonkar, S., Shandil, R.K., Yadav, R., Bharath, S., Marcel, N. et al (2009) Inactivation of the ilvB1 gene in Mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice. Microbiology (Reading), 155, 2978-2987.
-
- Beites, T., O'Brien, K., Tiwari, D., Engelhart, C.A., Walters, S., Andrews, J. et al (2019) Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development. Nature Communications, 10, 4970.
-
- Berney, M., Berney-Meyer, L., Wong, K.-W., Chen, B., Chen, M., Kim, J. et al (2015) Essential roles of methionine and S-adenosylmethionine in the autarkic lifestyle of Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America, 112, 32, 10008-10013.
-
- Bosch, B., DeJesus, M.A., Poulton, N.C., Zhang, W., Engelhart, C.A., Zaveri, A. et al (2021) Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis. Cell. S0092-8674(21)00824-2.
-
- Botella, L., Vaubourgeix, J., Livny, J. & Schnappinger, D. (2017) Depleting Mycobacterium tuberculosis of the transcription termination factor Rho causes pervasive transcription and rapid death. Nature Communications, 8, 1-10.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical